Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.

Chronic Disease Diet Humans Inflammation / etiology Inflammatory Bowel Diseases / epidemiology Leukocyte L1 Antigen Complex Manitoba / epidemiology Risk Factors

Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
19 01 2021
Historique:
received: 16 01 2020
pubmed: 25 3 2020
medline: 8 2 2022
entrez: 25 3 2020
Statut: ppublish

Résumé

We aimed to investigate (1) the stability of inflammatory aspects of diet over 1 year among persons with inflammatory bowel disease (IBD) and (2) the impact of change in diet on changes in inflammation and IBD symptoms over 1 year. Participants were recruited to the Manitoba Living with IBD Study and completed the Harvard Food Frequency Questionnaire (FFQ). The Dietary Inflammatory Index (DII) and the Empirical Dietary Inflammatory Index (EDII) were used to calculate the inflammatory potential of the diet. Inflammation was measured by fecal calprotectin (≥250 µg/g). Symptoms were measured by the IBD Symptom Inventory (IBDSI). All measures were obtained at baseline and 1 year. Dietary Inflammatory Index and Empirical Dietary Inflammatory Index scores >0 and <0 reflect pro- and anti-inflammatory diet, respectively. Variance components analyses were used to describe diet stability. Associations between changes in diet and changes in active inflammation and symptoms were assessed using ordinal logistic regression and multilevel linear regression modeling. One hundred thirty-five participants (66% CD) were included. Approximately one third of the variance in EDII (36%) and DII (33%) scores was explained by changes in diet over time. Each unit increase in the change in EDII (baseline to follow-up) was associated with a greater odds of FCAL, indicating active inflammation (>250 µg/g; odds ratio, 3.1; 95% confidence interval [CI], 1.02-9.93; P = 0.04) and with a rise in IBDSI of 6.7 (95% CI, 1.0-12.4; P = 0.022; theoretical IBDSI range, 0-81). There was no association between changes in DII and changes in FCAL or IBDSI. The EDII, but not the DII, may have utility to identify the inflammatory potential of diet. This inflammatory potential can contribute to inflammation and/or disease symptoms in persons with IBD.

Sections du résumé

BACKGROUND
We aimed to investigate (1) the stability of inflammatory aspects of diet over 1 year among persons with inflammatory bowel disease (IBD) and (2) the impact of change in diet on changes in inflammation and IBD symptoms over 1 year.
METHODS
Participants were recruited to the Manitoba Living with IBD Study and completed the Harvard Food Frequency Questionnaire (FFQ). The Dietary Inflammatory Index (DII) and the Empirical Dietary Inflammatory Index (EDII) were used to calculate the inflammatory potential of the diet. Inflammation was measured by fecal calprotectin (≥250 µg/g). Symptoms were measured by the IBD Symptom Inventory (IBDSI). All measures were obtained at baseline and 1 year. Dietary Inflammatory Index and Empirical Dietary Inflammatory Index scores >0 and <0 reflect pro- and anti-inflammatory diet, respectively. Variance components analyses were used to describe diet stability. Associations between changes in diet and changes in active inflammation and symptoms were assessed using ordinal logistic regression and multilevel linear regression modeling.
RESULTS
One hundred thirty-five participants (66% CD) were included. Approximately one third of the variance in EDII (36%) and DII (33%) scores was explained by changes in diet over time. Each unit increase in the change in EDII (baseline to follow-up) was associated with a greater odds of FCAL, indicating active inflammation (>250 µg/g; odds ratio, 3.1; 95% confidence interval [CI], 1.02-9.93; P = 0.04) and with a rise in IBDSI of 6.7 (95% CI, 1.0-12.4; P = 0.022; theoretical IBDSI range, 0-81). There was no association between changes in DII and changes in FCAL or IBDSI.
CONCLUSION
The EDII, but not the DII, may have utility to identify the inflammatory potential of diet. This inflammatory potential can contribute to inflammation and/or disease symptoms in persons with IBD.

Identifiants

DOI: 10.1093/ibd/izaa052 PMID: 32206803 PMC: PMC7813750
pubmed: 32206803
pii: 5811181
doi: 10.1093/ibd/izaa052
pmc: PMC7813750
doi:

Substances chimiques

Leukocyte L1 Antigen Complex 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-202

Subventions

Organisme : CIHR
ID : 130539
Pays : Canada

Informations de copyright

© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Gastroenterol. 2010 Jan;105(1):162-9
pubmed: 19755969
J Nutr. 2016 Aug;146(8):1560-70
pubmed: 27358416
Nutr Hosp. 2014 Mar 01;29(3):575-81
pubmed: 24559002
Oncotarget. 2018 May 8;9(35):24028-24040
pubmed: 29844870
Br J Nutr. 2015 Jun 14;113(11):1819-27
pubmed: 25871645
Eur J Nutr. 2019 Jun;58(4):1747-1756
pubmed: 30027314
J Nutr. 2017 Aug;147(8):1567-1577
pubmed: 28659407
Clin Gastroenterol Hepatol. 2014 Oct;12(10):1592-600
pubmed: 24107394
Biometrics. 1986 Jun;42(2):401-12
pubmed: 3741978
Am J Epidemiol. 1999 May 1;149(9):876-83
pubmed: 10221325
BMC Gastroenterol. 2012 Jan 10;12:5
pubmed: 22233279
J Occup Environ Med. 2014 Sep;56(9):986-9
pubmed: 25046320
J Nutr. 2003 Nov;133(11):3625-9
pubmed: 14608085
Ann Epidemiol. 1999 Apr;9(3):178-87
pubmed: 10192650
Br J Nutr. 2015 Jul 14;114(1):152-8
pubmed: 26050563
Anaerobe. 2013 Dec;24:117-20
pubmed: 23548695
Br J Nutr. 2015 Feb 28;113(4):665-71
pubmed: 25639781
Transl Res. 2012 Jul;160(1):29-44
pubmed: 22687961
JAMA Oncol. 2018 Mar 1;4(3):366-373
pubmed: 29346484
Aliment Pharmacol Ther. 2009 Jul 1;30(2):99-112
pubmed: 19438426
Can J Gastroenterol Hepatol. 2016;2016:2483261
pubmed: 27774443
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S13-S23
pubmed: 31095702
Immunity. 2014 Jun 19;40(6):833-42
pubmed: 24950203
Inflamm Bowel Dis. 2016 Feb;22(2):345-54
pubmed: 26717318
Nutr Cancer. 2016;68(3):404-9
pubmed: 27030369
Eur J Epidemiol. 2003;18(9):855-61
pubmed: 14561044
Gastroenterol Clin North Am. 2012 Jun;41(2):483-95
pubmed: 22500530
Inflamm Bowel Dis. 2013 Jan;19(1):66-72
pubmed: 22467242
Clin Exp Allergy. 2015 Jan;45(1):177-83
pubmed: 24708388
Ann Epidemiol. 2015 Jun;25(6):398-405
pubmed: 25900255
Am J Clin Nutr. 2000 Oct;72(4):912-21
pubmed: 11010931
Eur J Nutr. 2004 Jun;43(3):160-8
pubmed: 15168038
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
JMIR Res Protoc. 2018 Nov 12;7(11):e11317
pubmed: 30425031
Br J Cancer. 2017 Sep 5;117(6):907-911
pubmed: 28772285

Auteurs

Kathy Vagianos (K)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.

Leigh Anne Shafer (LA)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Internal Medicine, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

Kelcie Witges (K)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.

Laura E Targownik (LE)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Clove Haviva (C)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.

Lesley A Graff (LA)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Clinical Health Psychology, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

Kathryn A Sexton (KA)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Clinical Health Psychology, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

Lisa M Lix (LM)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Community Health Sciences, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

Michael Sargent (M)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Internal Medicine, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

Charles N Bernstein (CN)

Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Internal Medicine, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Association Between Change in Inflammatory...
questionsmedicales.fr › Phénomènes physiologiques › Alimentation et nutrition › Phénomènes physiologiques nutritionnels › Régime alimentaire › Association Between Change in Inflammatory...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Association Between Change in Inflammatory...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Association Between Change in Inflammatory...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies inflammatoires intestinales › Association Between Change in Inflammatory...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Complexe antigénique L1 leucocytaire › Association Between Change in Inflammatory...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › Canada › Manitoba › Association Between Change in Inflammatory...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Association Between Change in Inflammatory...